Featured Research

from universities, journals, and other organizations

New Treatment Option Emerging For Some With Early Stage Lung Cancer

Date:
November 6, 2009
Source:
Georgetown University Medical Center
Summary:
Patients with early stage, non-small cell lung cancer who are not able to undergo surgery, now have a highly effective treatment option. Physicians say that option, radical stereotactic radiosurgery performed with CyberKnife, leads to a 100 percent overall survival after three years in patients with good lung function before treatment.

Patients with early stage, non-small cell lung cancer who are not able to undergo surgery, now have a highly effective treatment option. Physicians say that option, radical stereotactic radiosurgery performed with CyberKnife, leads to a 100 percent overall survival after three years in patients with good lung function before treatment.

These are the results of a study presented today at the annual CHEST meeting in San Diego. The study is a semifinalist for an Alfred Soffer Research Award, selected for "outstanding original scientific research."

For patients with small tumors characterized as early-stage disease, surgical removal of the affected lobe (lobectomy) is the standard of care. However, surgery is sometimes not an option because of other pre-existing medical conditions such as emphysema or heart disease.

"Our goal has been to find a reasonable option for patients who don't want or can't tolerate surgery," says the study's lead author, Brian T. Collins, MD, a radiation oncologist with the Lombardi Comprehensive Cancer Center at Georgetown University Hospital. "What we discovered is a very promising option that may be relevant for other stage one patients as well. More follow up with these patients is planned to see how they progress five years after treatment."

Twenty-four patients were treated as part of the study. Each patient's "forced expiratory volume in 1 second" or FEV1 was measured.

"We use the FEV1 to grade the severity of a patient's COPD," says Eric D. Anderson, MD, a pulmonologist at Georgetown University Hospital and presenting author of the abstract. "It measures the ability of a patient to exhale forcefully." COPD stands for Chronic Obstructive Pulmonary Disease and is commonly referred to as emphysema.

At an average follow up of 36 months, the overall survival for all patients was 79 percent with five deaths occurring due to progressive lung dysfunction. For patients with a better FEV1, survival was 100 percent.

Collins says the treatment was well tolerated with mild fatigue only reported by the majority of patients.

"What we also learned from this study is that patients with poorer lung functioning don't do nearly as well," Collins explained. The overall survival in this group of patients was only 30 percent.

"This information is important for the doctor and patient when making treatment decisions," says Collins. "In treating someone with poor lung function, it would seem prudent to modify the treatment dose in order to reduce further damage to the lungs that stereotactic radiosurgery causes."

Lung cancer is the leading cause of cancer deaths with more than 215,020 people diagnosed each year and 161,804 dying of the disease, according to the American Cancer Society. While there is no screening test for lung cancer that would allow doctors to find the disease in its earliest, most curable stage, some tumors are found early because of medical tests being done for other conditions.

"These results are important because lung cancer is typically the result of long term smoking which causes significant health problems like emphysema. For these patients traditional lung surgery can be too risky because of their other health issues. This study shows that CyberKnife is a viable and promising option for patients to consider when their lung tumor has not spread to the lymph nodes or to distant parts of the body and surgery is too high-risk," explains Collins.

The study was funded by the CyberKnife Society. Collins reports receiving compensation for clinical consulting by ACCURAY, the maker of the CyberKnife. Anderson has received educational honoraria from Accuray.


Story Source:

The above story is based on materials provided by Georgetown University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Georgetown University Medical Center. "New Treatment Option Emerging For Some With Early Stage Lung Cancer." ScienceDaily. ScienceDaily, 6 November 2009. <www.sciencedaily.com/releases/2009/11/091103174206.htm>.
Georgetown University Medical Center. (2009, November 6). New Treatment Option Emerging For Some With Early Stage Lung Cancer. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2009/11/091103174206.htm
Georgetown University Medical Center. "New Treatment Option Emerging For Some With Early Stage Lung Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/11/091103174206.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Obama Orders Military Response to Ebola

Obama Orders Military Response to Ebola

AP (Sep. 16, 2014) Calling the Ebola outbreak in West Africa a potential threat to global security, President Barack Obama is ordering 3,000 U.S. military personnel to the stricken region amid worries that the outbreak is spiraling out of control. (Sept. 16) Video provided by AP
Powered by NewsLook.com
UN: 20,000 Could Be Infected With Ebola by Year End

UN: 20,000 Could Be Infected With Ebola by Year End

AFP (Sep. 16, 2014) Nearly $1.0 billion dollars is needed to fight the Ebola outbreak raging in west Africa, the United Nations say, warning that 20,000 could be infected by year end. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins